UTI Treatment: Antibiotics, Symptom Relief & Prevention Strategies
Urinary Tract Infection (UTI): Evidence-Based Treatment
UTIs are typically bacterial (E. coli 75–90%). Treatment: targeted antibiotics + supportive care.
First-Line Antibiotics (Uncomplicated Cystitis, Women)
| Agent | Dose & Duration | Notes |
| Nitrofurantoin | 100 mg BID × 5 days | Low resistance; concentrates in urine; avoid if CrCl <30 |
| Trimethoprim-sulfamethoxazole (TMP-SMX) | 160/800 mg BID × 3 days | If local E. coli resistance <20% |
| Fosfomycin | 3 g single dose | Convenient; lower efficacy vs. others |
| Pivmecillinam | 400 mg TID × 3–7 days | Non-US; excellent stewardship profile |
Alternative / Complicated UTI Agents
- Fluoroquinolones (cipro, levo) – reserve; resistance, tendinitis, aortic risk
- Beta-lactams (amox-clav, cefdinir) – less effective, more resistance
- IV agents (ceftriaxone, ertapenem) – pyelonephritis, sepsis
Symptom Management
- Phenazopyridine: Urinary analgesic (200 mg TID × 2 days max); orange urine
- NSAIDs: Ibuprofen for dysuria/inflammation (may reduce antibiotic need in mild cases)
- Hydration: 2–3 L/day; flushes bacteria
- Avoid irritants: Caffeine, alcohol, spicy foods
Adjunctive / Preventive
- Probiotics (Lactobacillus): May reduce recurrence (vaginal > oral)
- Cranberry (PACs): Mixed evidence; not treatment
- Vaginal estrogen (postmenopausal): Restores lactobacilli, ↓ UTI 50–75%
- Behavioral: Void post-coitus, wipe front-back, avoid diaphragms/spermicide
Follow-Up
- Uncomplicated: No test-of-cure if symptoms resolve
- Pyelonephritis/complicated: Repeat culture 1–2 wks post-treatment
- Recurrent (≥3/yr or ≥2/6mo): Urology eval, prophylaxis consideration
Complete the prescribed course. Resistance is driven by incomplete treatment and overuse.
Urinary Disorders - Related Articles